Director of The Centers for Disease Control and Prevention (CDC) Rochelle Walensky, of the United States; Pfizer-Biontech gave the green light for the use of the corona virus vaccine For children 5 to 11 years old.
His decision came after the recommendation of the CDC Advisory Board. 14 votes in favor and one vote against.
Members of the ACIP, which reviewed performance and safety data, said The benefits of the vaccine outweigh the risks, and they alternately spoke in favor of vaccinating children.
“We know that millions of parents are interested in vaccinating their children. With this decision, we have recommended that about 28 million children be vaccinated against the Govt-19 vaccine.” Valensky said in a statement. “As a mother, I encourage parents to talk to their pediatrician, school nurse or local pharmacist to learn more about vaccination and the importance of getting vaccinated.”
“Pediatric Infectious Diseases Association, the world’s largest organization of pediatricians, Strongly supports global recommendations for COVID-19 vaccination for children 5 to 11 years of age, As approved by the FDA, “said Dr. Sean O’Leary, Associate Professor of Pediatrics at the Colorado Children’s Hospital.
“Today is a Memorial Day in the course of this epidemic”, Valensky began its discussions with the advisory board early Tuesday. He noted that while the risk of serious illness and death is lower in young children than in adults, it is true that COVID-19 has had a profound social, mental and educational impact on young people, including the widening of learning imbalances. .
“There are children in the second grade who do not have a normal school year.” Valensky had said hours ago. “The vaccine for children has the power to change that.”
Several team members who cared for children admitted to the hospital noted that parents would like to ask questions Vaccines are safe and much better than betting that your baby will escape the corona virus infection.
“I have vaccinated my children”Dr Helen Keepe Talbot of Vanderbilt University said he would not recommend anything until it was convenient for other families. “We have seen the devastation of this disease.”
The long-awaited result comes a few days after vaccination It was approved By the Food and Drug Administration (FDA) and can Green light for vaccination campaign for young children.
This is an action created Great Anticipation Millions of families are trying to protect their children from the virus and improve the security of the United States before the winter hits. That is calculated About 28 million children in this group are eligible for Pfizer’s pediatric medication., Which is one-third used by adults, With two injections at three-week intervals.
With this consent, children between the ages of 5 and 11 in the United States They may start vaccinating this week. The first children will be fully protected at Christmas.
States are preparing to distribute vaccines – in bottles with orange caps, to differentiate them from the adult dose – as soon as the government gives the green light. More than 25,000 pediatricians and other primary care providers have declared themselves vaccine providers.
In the United States, Nearly 2 million children between the ages of 5 and 11 were infected with Govt-19 and at least 172 died, According to the CDC. The statistics are low compared to the total cases (45.8 million) and deaths (over 743,000) in the country, but they are worrying.
On October 26, the Medical Council of U.S. Government Advisers voted Recommend approval for Pfizer’s Govit-19 vaccine for children 5 to 11 years of age. Last Friday, The FDA gave its approval.
“When I hear about children being admitted to the ICU, having long-term results after their covia disease, and infant mortality, it is clear to me that the benefits outweigh the risks.Amanda Cohn of the CDC, who voted in favor, said. With 17 votes in favor, one did not vote.
This was revealed in a study conducted with primary school children Pfizer vaccines prevent symptomatic infections in 91% of cases, Although this is about one-third of the dose that adolescents and adults receive.
In a preliminary study last week, FDA officials said the risk of a very unusual side effect of protection would be “very high” In almost all infectious conditions.
With information from AFP and AP